Skip to main content
Log in

Typhoid vaccine Vi conjugate cost effective in various settings

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2016 US dollars

  2. disability-adjusted life-year

Reference

  • Lo NC, et al. Comparison of Strategies and Incidence Thresholds for Vi Conjugate Vaccines Against Typhoid Fever: A Cost-effectiveness Modeling Study. Journal of Infectious Diseases : 12 Feb 2018. Available from: URL: http://doi.org/10.1093/infdis/jix598

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Typhoid vaccine Vi conjugate cost effective in various settings. PharmacoEcon Outcomes News 798, 33 (2018). https://doi.org/10.1007/s40274-018-4780-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4780-y

Navigation